Company Filing History:
2 out of 1,209 
2 out of 517 
2 out of 2,963 
Years Active: 2022-2025
Title: Celebrating Innovator Laura Strauss: Pioneer in Immunotherapeutic Antibodies
Introduction: Laura Strauss, an accomplished inventor based in Boston, MA, has made significant contributions to the field of immunotherapy through her innovative work on monoclonal antibodies. With a total of two patents to her name, her research focuses primarily on enhancing our understanding and treatment of programmed cell death 1 (PD-1) signaling.
Latest Patents: Laura’s latest patents revolve around the groundbreaking "Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies." This invention delves into the discovery of monoclonal and polyclonal antibodies that specifically bind to phosphorylated PD-1. It encompasses immunoglobulins, polypeptides, and nucleic acids, along with methods for their diagnostic, prognostic, and therapeutic applications. The second patent, titled "Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and using thereof," complements her first by further detailing the utilization of these unique antibodies in various medical contexts.
Career Highlights: Laura Strauss has had a rewarding career, contributing her expertise and innovative spirit at esteemed institutions. She has worked with the Dana-Farber Cancer Institute, Inc. and Beth Israel Deaconess Medical Center, Inc., where her cutting-edge research has played a vital role in advancing cancer therapies.
Collaborations: In her journey, Laura has collaborated with notable colleagues, including Gordon James Freeman and Vassiliki A. Boussiotis. These partnerships have amplified her research efforts and contributed to the successful development of her patented innovations.
Conclusion: Laura Strauss exemplifies the spirit of innovation and dedication to scientific advancement in the field of immunotherapy. Through her patents, she continues to impact the medical community and enhance therapeutic methodologies, paving the way for groundbreaking treatments. Her work not only showcases the importance of research collaboration but also highlights the critical role of inventors in transforming healthcare.